Keyword: Andy Roberts

  • KEDRC Makes Cobalt Policy Recommendation

    The Kentucky Equine Drug Research Council will advise the Kentucky Horse Racing Commission to adopt policies on the mineral cobalt in line with a Racing Medication and Testing Consortium recommendation.

  • KY Drug Council Moves Toward Uniformity

    A council that makes recommendations on medication policies for the Kentucky Horse Racing Commission will go along with several changes in withdrawal times and threshold levels.

  • Jockey Club Urging Potential Salix Study

    The Jockey Club has called on leading industry organizations to come together to conduct a Salix study that would examine the timing of administration on the medication used to prevent exercise-induced pulmonary hemorrhage.

  • Study Links Cell Damage to Corticosteroids

    Initial results of a study conducted by the University of Kentucky Gluck Equine Research Center suggest accepted dosage levels for several corticosteroids commonly used in racing should be examined.

  • Uniform Drug Reform Discussed in Kentucky

    An initial introduction in Kentucky of the Mid-Atlantic Uniform Medication Program received raised eyebrows, but supporters of the changes are encouraged that the important racing state is giving the program consideration.

  • Split Over Race-Day Salix Continues in KY

    The Kentucky Horse Racing Commission May 16 kept alive a proposed regulation to phase out over three years race-day furosemide for graded and listed stakes, but not before the Equine Drug Research Council voted to reject it.